Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF …

M Bećarević - Journal of Thrombosis and Thrombolysis, 2017 - Springer
Antiphospholipid syndrome (APS) is an autoimmune disease that is characterized by arterial
and/or venous thrombosis and/or recurrent pregnancy losses. Obstetric APS (OAPS) is …

A comprehensive review of thrombogenic mechanisms in APS

R Aguilar-Valenzuela… - The Open …, 2010 - benthamopen.com
The antiphospholipid syndrome (APS) is an acquired thombophilia, which is characterized
by one or more thrombotic episodes and obstetric complications in the presence of …

[HTML][HTML] Differences in endothelial activation and dysfunction induced by antiphospholipid antibodies among groups of patients with thrombotic, refractory, and non …

M Velásquez, LF Peláez, M Rojas… - Frontiers in …, 2021 - frontiersin.org
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by pregnancy
morbidity or thrombosis and persistent antiphospholipid antibodies (aPL) that bind to the …

Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation

M Adams - Seminars in thrombosis and hemostasis, 2008 - thieme-connect.com
The antiphospholipid syndrome (APS) is characterized by clinical manifestations such as
venous and arterial thrombosis, thrombocytopenia and/or recurrent pregnancy loss, as well …

Molecular mechanisms of “antiphospholipid antibodies” and their paradoxical role in the pathogenesis of “seronegative APS”

R Misasi, A Longo, S Recalchi, D Caissutti… - International Journal of …, 2020 - mdpi.com
Antiphospholipid Syndrome (APS) is an autoimmune disease characterized by arterial
and/or venous thrombosis and/or pregnancy morbidity, associated with circulating …

From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome

VX Du, H Kelchtermans, PG de Groot, B de Laat - Thrombosis Research, 2013 - Elsevier
The antiphospholipid syndrome (APS) is diagnosed by the combination of vascular
thrombosis and/or pregnancy morbidity and the detection of antiphospholipid antibodies …

[HTML][HTML] New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome

Y Fujieda, O Amengual - European Journal of Rheumatology, 2021 - ncbi.nlm.nih.gov
Antiphospholipid syndrome (APS) is a systemic disorder clinically characterized by
widespread thrombosis and obstetric complications associated with the persistent presence …

Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome

O Amengual, T Atsumi, T Koike - Current Vascular …, 2011 - ingentaconnect.com
The antiphospholipid syndrome (APS) is an autoimmune disease in which recurrent
vascular thrombosis, pregnancy morbidity or a combination of these events is associated …

Antiphospholipid syndrome

M Khamashta, M Taraborelli, S Sciascia… - Best practice & research …, 2016 - Elsevier
Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy …

Antiphospholipid antibody-mediated thrombotic mechanisms in antiphospholipid syndrome: towards pathophysiology-based treatment

A Islam, F Alam, T Haryo Sasongko… - Current …, 2016 - ingentaconnect.com
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by a
persistently high titer of antiphospholipid antibodies (aPLs). In addition to pregnancy …